Last reviewed · How we verify
Treatment of colorectal cancer that has spread to the liver and the esophagus — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Folfiri | folfiri | Pfizer | chemotherapy | DNA replication and repair |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in Treatment of colorectal cancer that has spread to the liver and the esophagus
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Treatment of colorectal cancer that has spread to the liver and the esophagus:
- Treatment of colorectal cancer that has spread to the liver and the esophagus treatment updates — RSS
- Treatment of colorectal cancer that has spread to the liver and the esophagus treatment updates — Atom
- Treatment of colorectal cancer that has spread to the liver and the esophagus treatment updates — JSON
Cite this brief
Drug Landscape (2026). Treatment of colorectal cancer that has spread to the liver and the esophagus — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/treatment-of-colorectal-cancer-that-has-spread-to-the-liver-and-the-esophagus. Accessed 2026-06-10.
Related
- Treatment of colorectal cancer that has spread to the liver and the esophagus full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing